Author/Authors :
Kassaian، Seyed-Ebrahim نويسنده , , Karbassi، Arsha نويسنده Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. , , Sahebjam، Mohammad نويسنده , , Aghajani، Hassan نويسنده Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. , , Amin، Ahmad نويسنده Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. , , Ahmadbeigi، Niloufar نويسنده Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. , , Abbasi، Kyomars نويسنده , , Salehiomran، Abbas نويسنده Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. , , Poorhosseini، Hamidreza نويسنده Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. , , Salarifar، Mojtaba نويسنده ,
Abstract :
Mitral regurgitation (MR) is a common valvular lesion in the general population with considerable impact on mortality and morbidity. The MitraClip System (Abbot Laboratories, Abbot Park, IL, USA) is a novel percutaneous approach for treating MR which involves mechanical edge-to-edge coaptation of the mitral leaflets. We present our initial experience with the MitraClip System in 5 patients. In our series, the cause of MR was both degenerative and functional. Two patients received two MitraClips due to unsatisfactory results after the implantation of the first clip. Acute procedural success was seen in 4 patients. Blood transfusion was required for 2 patients. All the patients, except one, reported improvement in functional status during a 2-month follow-up period. Our initial experience with MitraClip implantation indicates that the technique seems feasible and promising with acceptable results and that it could be offered to a broader group of patients in the near future.
